HIV Research for Prevention Conference combining AIDS Vaccine & Microbicides

描述（由申请人提供）：本拨款申请的目的是请求资金部分支持规划、组织和主办2014年艾滋病毒预防研究：疫苗、杀微生物剂和基于arv的预防科学会议（R4P2014），这是一个国际会议。R4P2014将是世界上第一个也是唯一一个致力于艾滋病毒生物医学预防研究的科学会议。其主要目标是帮助在生物医学预防研究中创造跨学科互动的机会；随着新的艾滋病毒预防方案的制定，扩大对交叉问题的讨论，并加强国际团体之间的协调和沟通。在过去几年中，寻求有效的艾滋病毒生物医学预防办法的进展比这一流行病开始以来的任何时候都更大、更快。最近在疫苗、基于抗逆转录病毒的杀微生物剂、预防准备、预防治疗和其他预防技术方面取得的突破为减少全球流行病的影响创造了新的机会。随着我们继续推进艾滋病毒生物医学预防研究，这一进展也为科学辩论带来了机会，并带来了新的挑战。最重要的是，这些进展告诉我们，有效的艾滋病毒预防需要多种方法的结合。考虑到这种新方法，我们提议在2014年召开一个新的、更广泛的预防研究会议——艾滋病预防研究。首届两年一次的会议将于2014年10月28日至31日在南非开普敦的开普敦国际会议中心举行。本次国际会议将汇集研究人员、倡导者、临床医生、决策者、私营部门合作伙伴和公共卫生专家，介绍、讨论和辩论基于抗逆转录病毒药物的预防、疫苗和艾滋病毒预防相关领域的最新研究。它将以它将取代的过去两年一次的杀微生物剂会议和每年一次的艾滋病疫苗会议的成功为基础并与之联系起来。会议将促进更大的协调、相互借鉴和合作。它还将提供一个论坛

DESCRIPTION (provided by applicant): The purpose of this grant application is to request funds to partially support planning, organizing and hosting HIV Research for Prevention 2014: Vaccine, Microbicide and ARV-based Prevention Science Conference (R4P2014), an international conference. R4P2014 will be the world's first and only scientific meeting dedicated to biomedical HIV prevention research. Its primary goals are to help create opportunities for trans-disciplinary interactions in biomedical prevention research; expand discussions of crosscutting issues as new HIV prevention options are developed, and increase coordination and communication among international groups. The pursuit of effective biomedical HIV prevention options has progressed further and faster in the last few years than at any time since the epidemic began. Recent breakthroughs in vaccines, ARV-based microbicides, PrEP, treatment for prevention and other prevention technologies create new opportunities to reduce the impact of the global epidemic. This progress also brings opportunity for scientific debate and creates new challenges as we continue to move HIV biomedical prevention research forward. Most importantly, these advances teach us that effective HIV prevention will require a combination of approaches. Reflective of this new approach, we propose a new, broader prevention research conference for 2014, HIV Research for Prevention. This first bi-annual meeting will take place 28-31 October 2014 at the Cape Town International Conference Centre in Cape Town, South Africa. This international conference will bring together researchers, advocates, clinicians, policy makers, private sector partners and public health experts to present, discuss, and debate the latest research in ARV-based prevention, vaccines and related areas of HIV prevention. It will build on and link to the successes of the past bi-annual Microbicide and annual AIDS Vaccine conferences it will replace. The conference will drive greater coordination, cross-fertilization and increased collaboration. It will also provide a forum to address cross-cutting issues, emphasizing the importance of combination prevention, and it will break down any existing research siloes between different prevention technologies. R4P 2014 will therefore have a significant impact on the advancement of scientific research in unique prevention areas with the potential to make significant progress in the prevention of HIV infection. The conference will attract between 1,200-1,500 members of the HIV prevention community and will provide 200 full and 100 partial scholarships as well as subsidized registration rates for early-career and lower-middle income country (LMIC) scientists. Information presented at the conference will be disseminated to give free, worldwide access to all who are unable to attend in person. Peer-reviewed abstracts will be published online in an open access journal, and posters will be available online as e-posters. All sessions will be available as webcasts, including free downloads of slides and audio on the conference web site.